Truveta

Seattle, United States Founded: 2020 • Age: 6 yrs
Healthcare data platform for learning services is provided.
Request Access

About Truveta

Truveta is a company based in Seattle (United States) founded in 2020.. Truveta has raised $515 million across 4 funding rounds from investors including Microsoft, Illumina and Regeneron Pharmaceuticals. Truveta offers products and services including Truveta Data, Truveta Language Model, Truveta Studio, and Genomics Solutions. Truveta operates in a competitive market with competitors including Carta Healthcare, Flywheel, Verana Health, Clearsense and nference, among others.

  • Headquarter Seattle, United States
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Health Technology & Digital Health
Healthcare → Biotechnology, Genomics & Life Sciences Research
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $515 M (USD)

    in 4 rounds

  • Latest Funding Round
    $320 M (USD), Series C

    Jan 13, 2025

  • Investors
    Microsoft

    & 8 more

  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Truveta

Truveta offers a comprehensive portfolio of products and services, including Truveta Data, Truveta Language Model, Truveta Studio, and Genomics Solutions. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Provides EHR data for research and analytics purposes.

Analyzes clinical notes and images for health insights.

Facilitates collaboration on health data studies and trials.

Supports drug discovery through genotypic and phenotypic data.

People of Truveta
Headcount 50-200
Employee Profiles 135
Board Members and Advisors 12
Employee Profiles
People
Nishant Gopalakrishnan
Principal Software Engineer
People
Adi Unnithan
VP Of Engineering
People
Kyle Fennelly
Director Of Partner Growth - Life Sciences And Emerging Biotech
People
Meredith Fossitt
Senior Software Engineer

Unlock access to complete

Board Members and Advisors
people
Robin Damschroder
Director
people
Nick Reddy
Director
people
Bobbie Byrne
Director
people
Daniel J. Roth
Director

Unlock access to complete

Funding Insights of Truveta

Truveta has successfully raised a total of $515M across 4 strategic funding rounds. The most recent funding activity was a Series C round of $320 million completed in January 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 4
  • Last Round Series C — $320.0M
  • First Round

    (13 Jul 2021)

  • Investors Count 9
Date Amount Transaction Name Valuation Lead Investors Investors
Jan, 2025 Amount Series C - Truveta Valuation

investors

Nov, 2021 Amount Series B - Truveta Valuation

investors

Sep, 2021 Amount Series A - Truveta Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Truveta

Truveta has secured backing from 9 investors, including institutional investors. Prominent investors backing the company include Microsoft, Illumina and Regeneron Pharmaceuticals. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Antibodies are developed for treating cancer, eye, and inflammatory diseases.
Founded Year Domain Location
Trinity Health is recognized for providing healthcare and community services.
Founded Year Domain Location
A chain of multispecialty hospitals is operated in New York.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Truveta

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Truveta

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Truveta Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Truveta

Truveta operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Carta Healthcare, Flywheel, Verana Health, Clearsense and nference, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
AI-driven clinical data management tools are offered to healthcare providers.
domain founded_year HQ Location
Cloud-based platform for healthcare data capture and analysis is offered.
domain founded_year HQ Location
Verana Health is focused on real-world data analytics in healthcare.
domain founded_year HQ Location
Healthcare analytics platforms and applications are developed for clinicians.
domain founded_year HQ Location
AI platform provided for clinical data analysis and insights.
domain founded_year HQ Location
Cloud-based clinical data management platform for healthcare providers
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Frequently Asked Questions about Truveta

When was Truveta founded?

Truveta was founded in 2020 and raised its 1st funding round 1 year after it was founded.

Where is Truveta located?

Truveta is headquartered in Seattle, United States. It is registered at Seattle, Washington, United States.

Who is the current CEO of Truveta?

Terry Myerson is the current CEO of Truveta.

Is Truveta a funded company?

Truveta is a funded company, having raised a total of $515M across 4 funding rounds to date.

What does Truveta do?

Truveta was founded in 2020 and is headquartered in Seattle, United States. Operations are focused on the healthcare sector, where a data platform is utilized for learning services. Real-world data from various health systems is aggregated and analyzed to support research and insights. The platform enables secure access to de-identified patient information for collaborative studies. Leadership is provided by CEO Terry Myerson, with emphasis placed on advancing evidence-based healthcare decisions.

Who are the top competitors of Truveta?

Truveta's top competitors include Carta Healthcare, ClearDATA and Verana Health.

What products or services does Truveta offer?

Truveta offers Truveta Data, Truveta Language Model, Truveta Studio, and Genomics Solutions.

Who are Truveta's investors?

Truveta has 9 investors. Key investors include Microsoft, Illumina, Regeneron Pharmaceuticals, Providence Health & Services, and Northwell.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available